Saranas™ Announces Initial Clinical Cases with the Early Bird™ Bleed Monitoring System
HOUSTON--(BUSINESS WIRE)--Sep 18, 2018--Saranas Inc., a medical device company with innovative technology for real-time detection and monitoring of internal bleeding during endovascular procedures, announced that the first clinical cases with Early Bird Bleed Monitoring System were performed at Atlantic Health System’s Morristown Medical Center (Morristown, NJ). The cases varied across multiple interventions including transcatheter aortic valve replacement (TAVR), hemodynamic support and standard percutaneous coronary interventions, demonstrating the versatility of the Early Bird to potentially improve patient safety with improved bleed status monitoring during and after endovascular access procedures.
“The Early Bird Bleed Monitoring System is designed to protect, and in some cases, save the lives of patients undergoing an endovascular procedure by allowing physicians to detect the onset of bleeding early and take appropriate steps to address the bleed before detrimental, irreversible, and life-threatening consequences occur,” said Saranas Chief Medical Officer Dr. Philippe Généreux. “The initial clinical cases have successfully demonstrated the versatility and potential benefit of the Early Bird across a wide variety of case types.”
“Our goal in the development of the Early Bird Bleed Monitoring System is to provide doctors with a groundbreaking tool to reduce bleeding complications and to improve clinical outcomes in patients undergoing endovascular procedures,” said Zaffer Syed, President and CEO of Saranas. “As we expand our clinical pilot to multiple US centers in the coming weeks, we look forward to gaining more insight and experience on the utility of bleed monitoring.”
The first in human experience with the Early Bird will be showcased in the following presentations at the Transcatheter Cardiovascular Therapeutics (TCT) meeting held September 21-25, 2018 in San Diego, CA:Friday, September 21, 2018, @ 2:25pm during Innovation Sessions: “Real-Time Bleed Detection and Monitoring: Initial Clinical Experience with the Early Bird™ Bleed Monitoring System” by Dr. Philippe Généreux Sunday, September 23, 2018, @7:32am during Breakfast Satellite Program: “Real Time Bleed Detection: Novel Saranas Early Bird Bleed Monitoring” by Dr. Philippe Généreux
The Early Bird Bleed Monitoring System includes a vascular access sheath with embedded sensors that are designed to detect and monitor bleeding from a blood vessel accidentally injured during endovascular procedures, such as TAVR, large bore hemodynamic support device placement, or other complex cardiovascular interventions, where the femoral artery or vein is used to obtain vascular access. The technology was invented at the Texas Heart Institute.
The Early Bird Bleed Monitoring System is not yet approved by the U.S. Food and Drug Administration and is currently available for investigational use only.
Saranas is a privately held Houston-based medical device company focused on improving patient outcomes through early detection and monitoring of internal bleeding complications. The company’s patented bleed monitoring system for vascular access procedures enables physicians to mitigate downstream consequences by addressing bleeding complications immediately, improving patient outcomes and lowering healthcare costs. For more information, visit www.saranas.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180918005321/en/
CONTACT: Saranas, Inc.
Zaffer Syed, 713-357-1049
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA TEXAS
INDUSTRY KEYWORD: SURGERY HEALTH BIOTECHNOLOGY CARDIOLOGY CLINICAL TRIALS MEDICAL DEVICES
SOURCE: Saranas, Inc.
Copyright Business Wire 2018.
PUB: 09/18/2018 05:00 AM/DISC: 09/18/2018 05:01 AM